Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma

doi:10.5306/wjco.v8.i3.255

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12615)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

777

WORD

425

HTML

4397

Figures (1-4)

337

Tables (1-1)

944

Sum=6880

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

938

Download

1648

Sum=2586

Publishing Process of This Article

Item

Count

Browse

1345

Download

1806

Sum=3151

Jun 10, 2017 (publication date) through Oct 26, 2025

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Minireviews

World J Clin Oncol. Jun 10, 2017; 8(3): 255-260
Published online Jun 10, 2017. doi: 10.5306/wjco.v8.i3.255

Table 1 Potential biomarkers in the pancreatic juice and bile of patients with pancreatic adenocarcinoma

Body fluid	Biomarker
Pancreatic ductal fluid	CA 19-9
	CEA
	K-ras
	p53 mutations
	DNA methylation alterations
	Mitochondrial DNA mutations
	S100 calcium-binding protein P (S100P)
	Human telomerase reverse transcriptase
	Matrix metalloproteinase-9
	Oncogene DJ1
	Alpha-1B-glycoprotein precursor
	MicroRNA- miR-205, miR-210
	Adnab-9
	S100A8 or A9
	Mucins MUC1, 2, 5AC, 5B, 6 and 13
Bile	CEA
	Mac-2-binding protein
	MUC4
	Vascular endothelial growth factor

CA 19-9: Cancer antigen 19-9; CEA: Carcinoembryonic antigen.

Full Size Table

Citation: Agrawal S. Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma. World J Clin Oncol 2017; 8(3): 255-260
URL: https://www.wjgnet.com/2218-4333/full/v8/i3/255.htm
DOI: https://dx.doi.org/10.5306/wjco.v8.i3.255